In late April, the Council for Economic Education submitted a letter to a special committee of the European Parliament, which was the pharmaceutical industry's latest attempt to safeguard the world's forests.The letter asked for financing for developing countries and stated that the pharmaceutical sector cannot develop new treatments without the plants and trees that provide the basis for many existing ones.
Consequently, companies trying to reduce their carbon footprint send most of their goods to the EU, a substantial export market.
There seems to be a lot of fine print on this.But by focusing on the manufacture and distribution of chemicals, pharmaceutical companies' long-distance shipping routes obscure the problem of how to reduce greenhouse gas emissions at the EU level.